Site Members can sign up for company wide alerts
Investigation Overview
June 12, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) shares over potential securities laws violations by Dicerna Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers o...
You must register (for free) or login to view the entire investigation.